Baseline factors at enrolment & univariate analysis of factors associated with not attending an HIV clinic four months post delivery.

1<p>Excludes 7 women with unknown age.</p>2<p>Excludes 47 women who were tested on admission for delivery.</p>3<p>Excludes 15 women with no ANC card available at the maternity ward.</p>4<p>Oral and injectable hormonal contraception, condoms and intrauterine contraceptive device.</p

Independent factors associated with not attending an HIV clinic four months post delivery¹.

1<p>Adjusted for age, tribe, total ANC visits during pregnancy, whether PMTCT medication was taken and disclosure of HIV status to any other person.</p

Proportion of HIV positive pregnant women receiving referral and attending an HIV clinic within 4 months post-partum.

1<p>Comprises 240 women tested at the antenatal clinic and 70 women tested at the maternity ward around delivery. Excludes 93 women who were not diagnosed HIV positive for the first time through PMTCT screening in this pregnancy.</p>2<p>Referral post-delivery but pre-discharge from hospital.</p>3<p>Attended an HIV clinic and was issued with HIV clinic attendance/treatment card.</p

Attrition in the cascade of HIV assessment and treatment steps taken by women identified as HIV positive through PMTCT services.

<p>Attrition in the cascade of HIV assessment and treatment steps taken by women identified as HIV positive through PMTCT services.</p

Cascade of referral and care for HIV-positive pregnant women in Tanzan.

<p>Cascade of referral and care for HIV-positive pregnant women in Tanzan.</p

Recommendations for provision of antiretroviral therapy to refugees and IDPs in stable settings.

<p>ART, antiretroviral therapy; MOH, Ministry of Health; NSP, National Strategic Plan; PEPFAR.</p

Results of UNHCR-sponsored evaluations conducted in Malaysia and Kenya.

a<p>≥25 weeks on treatment; cut-offs: Malaysia, 40 copies/ml and Kenya, 5,000 copies/ml. The difference in cut-offs was due to collection method: blood plasma was collected using routine phlebotomy services in Malaysia and whole blood was collected as dried blood spots in Kenya. Note that the 5000 copies/ml cut-off used here differs from the 1000 copies/ml reported previously <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001643#pmed.1001643-Mendelsohn3" target="_blank">[29]</a>. A higher cut-off has been used to conform to current guidelines <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001643#pmed.1001643-World2" target="_blank">[36]</a>.</p>b<p>≥30 days on treatment.</p

Ranking of potential barriers and facilitators for a successful HPV vaccination programme.

<p>Ranking of potential barriers and facilitators for a successful HPV vaccination programme.</p

Socio-demographic characteristics among 7300 male participants in the MkV further survey, and their associations with male circumcision.

*<p>Adjusted for age, ethnic group and religion.</p><p>¹Of 7300 surveyed, 123 males had missing data for circumcision status. ² Odds ratios not calculable for intervention and comparison group as model is conditional on community. ³8 missing values ⁴34 missing values.</p

Male circumcision status and risk of HIV and other STIs among 6672 male participants in the MkV further survey.

<p>¹Adjusted for age and ever used a condom, ² Adjusted for age only, ³Adjusted for age and religion, ⁴Adjusted for age and used condom with last sexual partner.</p><p>TPPA+  =  Serodia <i>Treponema pallidum</i> particle agglutination test. RPR  =  Immutrep carbon antigen rapid plasma reagin test.</p><p>Missing values for STIs ranged from 10 to 41.</p